Assessing the usefulness of anticardiolipin antibody assays: A cautious approach is suggested by high variation and limited consensus in multilaboratory testing

American Journal of Clinical Pathology

Volumn 118, Issue 4, 2002, Pages 548-557

  Favaloro, Emmanuel J ^a,b   Silvestrini, Roger ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b Sydney West Area Health Service NSW Health   (Australia)

Author keywords

Anticardiolipin antibody; Antiphospholipid antibody; Antiphospholipid syndrome; Assay; Laboratory assessment; Quality assurance

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN M;

ARTICLE; CONSENSUS; IMMUNOASSAY; LABORATORY TEST; PRIORITY JOURNAL; QUALITY CONTROL; BLOOD; CLINICAL TRIAL; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; HEALTH CARE QUALITY; HUMAN; MULTICENTER STUDY; OBSERVER VARIATION; REFERENCE VALUE; REPRODUCIBILITY; STANDARD;

ANTIBODIES, ANTICARDIOLIPIN; DIAGNOSTIC TESTS, ROUTINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; OBSERVER VARIATION; QUALITY ASSURANCE, HEALTH CARE; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 0036780682     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/JAMH-GDQ6-6BYK-DW6J     Document Type: Article

References (18)

1. Harris EN. Antiphospholipid antibodies. Br J Haematol. 1990;70:1-9.
2. Field SL, Brighton TA, McNeil HP, et al. Recent insights into antiphospholipid antibody-mediated thrombosis. Baillieres Clin Haematol. 1999;12:407-422.
3. Harris EN, Gharavi AEM, Boey ML, et al. Anti-cardiolipin antibodies: detection by radio-immunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983;ii:1211-1214.
4. Triplett DA, Brandt JT, Musgrave KA, et al. The relationship between lupus anticoagulants and antibodies to phospholipid. JAMA. 1988;259:550-554.
5. Ginsberg JS, Wells PS, Brill-Edwards P, et al. Antiphospholipid antibodies and venous thromboembolism. Blood. 1995;10:3685-3691.
6. Pengo V, Thiagarajan P, Shapiro SS, et al. Immunological specificity and mechanism of action of IgG lupus anticoagulants. Blood. 1987;70:69-76.
7. Harris EN, Chan JKH, Asherson RA, et al. Thrombosis, recurrent fetal loss, thrombocytopenia: predictive value of IgG anticardiolipin antibodies. Arch Intern Med. 1986;146:2153-2156.
8. Ginsberg KS, Liang MH, Newcomer L, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Intern Med. 1992;117:997-1002.
9. Court EL. Lupus anticoagulants: pathogenesis and laboratory diagnosis. Br J Biomed Sci. 1997;54:287-298.
10. Galli M, Finazzi G, Barbui T. Antiphospholipid antibodies: predictive value of laboratory tests. Thromb Hoemost. 1997;77:75-78.
11. Vermylen J, Hoylaerts MF, Amout J. Antibody-mediated thrombosis. Thromb Haemost. 1997;77:420-426.
12. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet. 1993;342:341-344.
13. McNeil HP, Krilis SA. Antiphospholipid antibodies. Aust N Z J Med. 1991;21:463-475.
14. Triplett DA. Protean clinical presentation of antiphospholipid antibodies (APA). Thromb Haemost. 1995;74:329-337.
15. Harris EN, Gharavi AE, Patel SP, et al. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol. 1987;68:215-222.
16. Favaloro EJ, Silvestrini R, Mohammed A. Clinical utility of anticardiolipin antibody assays: high inter-laboratory variation and limited consensus by participants of external quality assurance programs signals a cautious approach. Pathology. 1999;31:142-147.
17. Tincani A, Allegri F, Sanmarco M, et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations: a cooperative project of the European Antiphospholipid Forum. Thromb Haemost. 2001;86:575-583.
18. Ichikawa K, Tsutsumi A, Atsumi T, et al. A chimeric antibody with the human gammal constant region as a putative standard for assays to detect IgG beta 2-glycoprotein I-dependent anticardiolipin and anti-beta 2-glycoprotein I antibodies. Arthritis Rheum. 1999;42:2461-2470.